Protein quality control and degradation in cardiomyocytes

Journal of Molecular and Cellular Cardiology

Volumn 45, Issue 1, 2008, Pages 11-27

  Wang, Xuejun ^a   Su, Huabo ^a   Ranek, Mark J ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Autophagy; Chaperones; Proteases; Proteasome; Signal transduction; Ubiquitin

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEASOME; PROTEIN KINASE B; SOMATOMEDIN C; TRANSCRIPTION FACTOR FOXO; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3;

AGING; AUTOPHAGY; CONGESTIVE HEART FAILURE; ENDOPLASMIC RETICULUM; ENZYME ACTIVE SITE; ENZYME ASSAY; ENZYME SUBSTRATE; FLUORESCENCE ANALYSIS; HEART FAILURE; HEART MUSCLE CELL; HEART STRESS; HEART VENTRICLE HYPERTROPHY; HUMAN; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN QUALITY; QUALITY CONTROL; REGULATORY MECHANISM; REVIEW; UBIQUITINATION;

ANIMALS; AUTOPHAGY; HEART FAILURE; HUMANS; MOLECULAR CHAPERONES; MUSCLE PROTEINS; MYOCYTES, CARDIAC; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN FOLDING; UBIQUITIN;

EID: 45549108538     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2008.03.025     Document Type: Review

References (174)

1. Wang X., and Robbins J. Heart failure and protein quality control. Circ Res 99 (2006) 1315-1328
2. Willis M.S., and Patterson C. Into the heart: the emerging role of the ubiquitin-proteasome system. J Mol Cell Cardiol 41 (2006) 567-579
3. Gomes A.V., Zong C., and Ping P. Protein degradation by the 26S proteasome system in the normal and stressed myocardium. Antioxid Redox Signal 8 (2006) 1677-1691
4. Hebert D.N., and Molinari M. In and out of the ER: protein folding, quality control, degradation, and related human diseases. Physiol Rev 87 (2007) 1377-1408
5. Rubinsztein D.C. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443 (2006) 780-786
6. Young J.C., Agashe V.R., Siegers K., and Hartl F.U. Pathways of chaperone-mediated protein folding in the cytosol. Nat Rev Mol Cell Biol 5 (2004) 781-791
7. Kumarapeli A.R., and Wang X. Genetic modification of the heart: chaperones and the cytoskeleton. J Mol Cell Cardiol 37 (2004) 1097-1109
8. Rosser M.F., Washburn E., Muchowski P.J., Patterson C., and Cyr D.M. Chaperone functions of the E3 ubiquitin ligase CHIP. J Biol Chem 282 (2007) 22267-22277
9. Tripathi V., Ali A., Bhat R., and Pati U. CHIP chaperones wild type p53 tumor suppressor protein. J Biol Chem 282 (2007) 28441-28454
10. Marques C., Guo W., Pereira P., Taylor A., Patterson C., Evans P.C., et al. The triage of damaged proteins: degradation by the ubiquitin-proteasome pathway or repair by molecular chaperones. FASEB J 20 (2006) 741-743
11. Kumar P., Ambasta R.K., Veereshwarayya V., Rosen K.M., Kosik K.S., Band H., et al. CHIP and HSPs interact with beta-APP in a proteasome-dependent manner and influence Abeta metabolism. Hum Mol Genet 16 (2007) 848-864
12. Patterson C., Ike C., Willis P.W.t., Stouffer G.A., and Willis M.S. The bitter end: the ubiquitin-proteasome system and cardiac dysfunction. Circulation 115 (2007) 1456-1463
13. Wang X., Osinska H., Klevitsky R., Gerdes A.M., Nieman M., Lorenz J., et al. Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice. Circ Res 89 (2001) 84-91
14. Rajasekaran N.S., Connell P., Christians E.S., Yan L.J., Taylor R.P., Orosz A., et al. Human alphaB-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice. Cell 130 (2007) 427-439
15. Chen Q., Liu J.B., Horak K.M., Zheng H., Kumarapeli A.R.K., Li J., et al. Intrasarcoplasmic amyloidosis impairs proteolytic function of proteasomes in cardiomyocytes by compromising substrate uptake. Circ Res 97 (2005) 1018-1028
16. Li H.H., Kedar V., Zhang C., McDonough H., Arya R., Wang D.Z., et al. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. J Clin Invest 114 (2004) 1058-1071
17. Willis M.S., Ike C., Li L., Wang D.Z., Glass D.J., and Patterson C. Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo. Circ Res 100 (2007) 456-459
18. Li H.H., Willis M.S., Lockyer P., Miller N., McDonough H., Glass D.J., et al. Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins. J Clin Invest 117 (2007) 3211-3223
19. Meiners S., Dreger H., Fechner M., Bieler S., Rother W., Gunther C., et al. Suppression of cardiomyocyte hypertrophy by inhibition of the ubiquitin-proteasome system. Hypertension 51 (2008) 302-308
20. Stansfield W.E., Tang R.H., Moss N.C., Baldwin A.S., Willis M.S., and Selzman C.H. Proteasome inhibition promotes regression of left ventricular hypertrophy. Am J Physiol Heart Circ Physiol 294 (2008) H645-H650
21. Willis M.S., Schisler J.C., and Patterson C. Appetite for destruction: E3 ubiquitin-ligase protection in cardiac disease. Future Cardiol 4 (2008) 65-75
22. Tu D., Li W., Ye Y., and Brunger A.T. Inaugural article: structure and function of the yeast U-box-containing ubiquitin ligase Ufd2p. Proc Natl Acad Sci U S A 104 (2007) 15599-15606
23. Li W., Tu D., Brunger A.T., and Ye Y. A ubiquitin ligase transfers preformed polyubiquitin chains from a conjugating enzyme to a substrate. Nature 446 (2007) 333-337
24. Woelk T., Sigismund S., Penengo L., and Polo S. The ubiquitination code: a signalling problem. Cell Div 2 (2007) 11
25. Hicke L., and Dunn R. Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins. Annu Rev Cell Dev Biol 19 (2003) 141-172
26. Hanna J., Meides A., Zhang D.P., and Finley D. A ubiquitin stress response induces altered proteasome composition. Cell 129 (2007) 747-759
27. Fielitz J., van Rooij E., Spencer J.A., Shelton J.M., Latif S., van der Nagel R., et al. Loss of muscle-specific RING-finger 3 predisposes the heart to cardiac rupture after myocardial infarction. Proc Natl Acad Sci U S A 104 (2007) 4377-4382
28. Fielitz J., Kim M.-S., Shelton J.M., Latif S., Spencer J.A., Glass D.J., et al. Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3. J Clin Invest 117 (2007) 2486-2495
29. Arya R., Kedar V., Hwang J.R., McDonough H., Li H.H., Taylor J., et al. Muscle ring finger protein-1 inhibits PKC{epsilon} activation and prevents cardiomyocyte hypertrophy. J Cell Biol 167 (2004) 1147-1159
30. Kedar V., McDonough H., Arya R., Li H.H., Rockman H.A., and Patterson C. Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I. Proc Natl Acad Sci U S A 101 (2004) 18135-18140
31. Lange S., Xiang F., Yakovenko A., Vihola A., Hackman P., Rostkova E., et al. The kinase domain of titin controls muscle gene expression and protein turnover. Science 308 (2005) 1599-1603
32. Spencer J.A., Eliazer S., Ilaria Jr. R.L., Richardson J.A., and Olson E.N. Regulation of microtubule dynamics and myogenic differentiation by MURF, a striated muscle RING-finger protein. J Cell Biol 150 (2000) 771-784
33. Chew E.H., and Hagen T. Substrate-mediated regulation of cullin neddylation. J Biol Chem 282 (2007) 17032-17040
34. Razeghi P., Baskin K.K., Sharma S., Young M.E., Stepkowski S., Essop M.F., et al. Atrophy, hypertrophy, and hypoxemia induce transcriptional regulators of the ubiquitin proteasome system in the rat heart. Biochem Biophys Res Commun 342 (2006) 361-364
35. Adams V., Linke A., Wisloff U., Doring C., Erbs S., Krankel N., et al. Myocardial expression of Murf-1 and MAFbx after induction of chronic heart failure: effect on myocardial contractility. Cardiovasc Res 73 (2007) 120-129
36. Sandri M., Sandri C., Gilbert A., Skurk C., Calabria E., Picard A., et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117 (2004) 399-412
37. Stitt T.N., Drujan D., Clarke B.A., Panaro F., Timofeyva Y., Kline W.O., et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14 (2004) 395-403
38. Haupt Y., Maya R., Kazaz A., and Oren M. Mdm2 promotes the rapid degradation of p53. Nature 387 (1997) 296-299
39. Toth A., Nickson P., Qin L.L., and Erhardt P. Differential regulation of cardiomyocyte survival and hypertrophy by MDM2, an E3 ubiquitin ligase. J Biol Chem 281 (2006) 3679-3689
40. Tian L.F., Li H.Y., Jin B.F., Pan X., Man J.H., Zhang P.J., et al. MDM2 interacts with and downregulates a sarcomeric protein, TCAP. Biochem Biophys Res Commun 345 (2006) 355-361
41. Spruill L.S., Baicu C.F., Zile M.R., and McDermott P.J. Selective translation of mRNAs in the left ventricular myocardium of the mouse in response to acute pressure overload. J Mol Cell Cardiol 44 (2008) 69-75
42. Balasubramanian S., Mani S., Shiraishi H., Johnston R.K., Yamane K., Willey C.D., et al. Enhanced ubiquitination of cytoskeletal proteins in pressure overloaded myocardium is accompanied by changes in specific E3 ligases. J Mol Cell Cardiol 41 (2006) 669-679
43. Lukashchuk N., and Vousden K.H. Ubiquitination and degradation of mutant p53. Mol Cell Biol 27 (2007) 8284-8295
44. Al-Ramahi I., Lam Y.C., Chen H.K., de Gouyon B., Zhang M., Perez A.M., et al. CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation. J Biol Chem 281 (2006) 26714-26724
45. Qian S.B., McDonough H., Boellmann F., Cyr D.M., and Patterson C. CHIP-mediated stress recovery by sequential ubiquitination of substrates and Hsp70. Nature 440 (2006) 551-555
46. Younger J.M., Chen L., Ren H.Y., Rosser M.F., Turnbull E.L., Fan C.Y., et al. Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator. Cell 126 (2006) 571-582
47. Nam Y.J., Mani K., Wu L., Peng C.F., Calvert J.W., Foo R.S., et al. The apoptosis inhibitor ARC undergoes ubiquitin-proteasomal-mediated degradation in response to death stimuli: identification of a degradation-resistant mutant. J Biol Chem 282 (2007) 5522-5528
48. Foo R.S., Chan L.K., Kitsis R.N., and Bennett M.R. Ubiquitination and degradation of the anti-apoptotic protein ARC by MDM2. J Biol Chem 282 (2007) 5529-5535
49. Salvesen G.S., and Duckett C.S. IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 3 (2002) 401-410
50. Bennett E.J., Shaler T.A., Woodman B., Ryu K.Y., Zaitseva T.S., Becker C.H., et al. Global changes to the ubiquitin system in Huntington's disease. Nature 448 (2007) 704-708
51. Rott R., Szargel R., Haskin J., Shani V., Shainskaya A., Manov I., et al. Monoubiquitylation of alpha-synuclein by SIAH promotes its aggregation in dopaminergic cells. J Biol Chem 283 (2008) 3316-3328
52. Lee J.T., Wheeler T.C., Li L., and Chin L.S. Ubiquitination of {alpha}-synuclein by Siah-1 promotes {alpha}-synuclein aggregation and apoptotic cell death. Hum Mol Genet 17 (2008) 906-917
53. Gong B., Cao Z., Zheng P., Vitolo O.V., Liu S., Staniszewski A., et al. Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell 126 (2006) 775-788
54. Weekes J., Morrison K., Mullen A., Wait R., Barton P., and Dunn M.J. Hyperubiquitination of proteins in dilated cardiomyopathy. Proteomics 3 (2003) 208-216
55. Sanbe A., Osinska H., Saffitz J.E., Glabe C.G., Kayed R., Maloyan A., et al. Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. Proc Natl Acad Sci U S A 101 (2004) 10132-10136
56. Kusmierczyk A.R., Kunjappu M.J., Funakoshi M., and Hochstrasser M. A multimeric assembly factor controls the formation of alternative 20S proteasomes. Nat Struct Mol Biol 15 (2008) 237-244
57. Rechsteiner M., and Hill C.P. Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors. Trends Cell Biol 15 (2005) 27-33
58. Tanahashi N., Murakami Y., Minami Y., Shimbara N., Hendil K.B., and Tanaka K. Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis. J Biol Chem 275 (2000) 14336-14345
59. Murata S., Udono H., Tanahashi N., Hamada N., Watanabe K., Adachi K., et al. Immunoproteasome assembly and antigen presentation in mice lacking both PA28alpha and PA28beta. EMBO J 20 (2001) 5898-5907
60. Li X., Amazit L., Long W., Lonard D.M., Monaco J.J., and O'Malley B.W. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. Mol Cell 26 (2007) 831-842
61. Chen X., Barton L.F., Chi Y., Clurman B.E., and Roberts J.M. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol Cell 26 (2007) 843-852
62. Li X., Lonard D.M., Jung S.Y., Malovannaya A., Feng Q., Qin J., et al. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome. Cell 124 (2006) 381-392
63. Powell S.R., Samuel S.M., Wang P., Divald A., Thirunavukkarasu M., Koneru S., et al. Upregulation of myocardial 11S-activated proteasome in experimental hyperglycemia. J Mol Cell Cardiol 44 (2008) 618-621
64. Rodgers K.J., and Dean R.T. Assessment of proteasome activity in cell lysates and tissue homogenates using peptide substrates. Int J Biochem Cell Biol 35 (2003) 716-727
65. Chen L., and Madura K. Rad23 promotes the targeting of proteolytic substrates to the proteasome. Mol Cell Biol 22 (2002) 4902-4913
66. Powell S.R., Davies K.J., and Divald A. Optimal determination of heart tissue 26S-proteasome activity requires maximal stimulating ATP concentrations. J Mol Cell Cardiol 42 (2007) 265-269
67. Verdoes M., Florea B.I., Menendez-Benito V., Maynard C.J., Witte M.D., van der Linden W.A., et al. A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo. Chem Biol 13 (2006) 1217-1226
68. Liu J., Chen Q., Huang W., Horak K.M., Zheng H., Mestril R., et al. Impairment of the ubiquitin-proteasome system in desminopathy mouse hearts. FASEB J 20 (2006) 362-364
69. Lindsten K., Menendez-Benito V., Masucci M.G., Dantuma N.P., Kumarapeli A.R., Horak K.M., et al. GFP reporter mouse models of UPS proteolytic function. FASEB J 20 (2006) 1027-1028
70. Bence N.F., Bennett E.J., and Kopito R.R. Application and analysis of the GFPu family of ubiquitin-proteasome system reporters. Methods Enzymol 399 (2005) 481-490
71. Dong X., Liu J., Zheng H., Glasford J.W., Huang W., Chen Q.H., et al. In situ dynamically monitoring the proteolytic function of the ubiquitin-proteasome system in cultured cardiac myocytes. Am J Physiol Heart Circ Physiol 287 (2004) H1417-H1425
72. Kumarapeli R.K.A., Horak K.M., Glasford J.W., Li J., Chen Q., Liu J., et al. A novel transgenic mouse model reveals deregulation of the ubiquitin-proteasome system in the heart by doxorubicin. FASEB J 19 (2005) 2051-2053
73. Link C.D., Fonte V., Hiester B., Yerg J., Ferguson J., Csontos S., et al. Conversion of green fluorescent protein into a toxic, aggregation-prone protein by C-terminal addition of a short peptide. J Biol Chem 281 (2006) 1808-1816
74. Pandey U.B., Nie Z., Batlevi Y., McCray B.A., Ritson G.P., Nedelsky N.B., et al. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447 (2007) 859-863
75. Bence N.F., Sampat R.M., and Kopito R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292 (2001) 1552-1555
76. Moon R.T. Wnt/beta-catenin pathway. Sci STKE (2005) 2005(271):cm1
77. Gao B., Lee S.M., and Fang D. The tyrosine kinase c-Abl protects c-Jun from ubiquitination-mediated degradation in T cells. J Biol Chem 281 (2006) 29711-29718
78. Skurk C., Izumiya Y., Maatz H., Razeghi P., Shiojima I., Sandri M., et al. The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling. J Biol Chem 280 (2005) 20814-20823
79. Ni Y.G., Berenji K., Wang N., Oh M., Sachan N., Dey A., et al. Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling. Circulation 114 (2006) 1159-1168
80. Gomes A.V., Zong C., Edmondson R.D., Li X., Stefani E., Zhang J., et al. Mapping the murine cardiac 26S proteasome complexes. Circ Res 99 (2006) 362-371
81. Drews O., Wildgruber R., Zong C., Sukop U., Nissum M., Gomes A.V., et al. Mammalian proteasome subpopulations with distinct molecular compositions and proteolytic activities. Mol Cell Proteomics 6 (2007) 2021-2031
82. Drews O., Zong C., and Ping P. Exploring proteasome complexes by proteomic approaches. Proteomics 7 (2007) 1047-1058
83. Cho Y.H., Yoo S.D., and Sheen J. Regulatory functions of nuclear hexokinase1 complex in glucose signaling. Cell 127 (2006) 579-589
84. Zhang F., Su K., Yang X., Bowe D.B., Paterson A.J., and Kudlow J.E. O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 115 (2003) 715-725
85. Zong C., Gomes A.V., Drews O., Li X., Young G.W., Berhane B., et al. Regulation of murine cardiac 20S proteasomes: role of associating partners. Circ Res 99 (2006) 372-380
86. Zhang F., Hu Y., Huang P., Toleman C.A., Paterson A.J., and Kudlow J.E. Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6. J Biol Chem 282 (2007) 22460-22471
87. Meiners S., Heyken D., Weller A., Ludwig A., Stangl K., Kloetzel P.M., et al. Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of mammalian proteasomes. J Biol Chem 278 (2003) 21517-21525
88. Liu Y., Liu X., Zhang T., Luna C., Liton P.B., and Gonzalez P. Cytoprotective effects of proteasome beta5 subunit overexpression in lens epithelial cells. Mol Vis 13 (2007) 31-38
89. Gus Y., Karni R., and Levitzki A. Subunit S5a of the 26S proteasome is regulated by antiapoptotic signals. FEBS J 274 (2007) 2815-2831
90. Narula J., Haider N., Arbustini E., and Chandrashekhar Y. Mechanisms of disease: apoptosis in heart failure - seeing hope in death. Nat Clin Pract Cardiovasc Med 3 (2006) 681-688
91. Galvez A.S., Diwan A., Odley A.M., Hahn H.S., Osinska H., Melendez J.G., et al. Cardiomyocyte degeneration with calpain deficiency reveals a critical role in protein homeostasis. Circ Res 100 (2007) 1071-1078
92. Sun X.M., Butterworth M., MacFarlane M., Dubiel W., Ciechanover A., and Cohen G.M. Caspase activation inhibits proteasome function during apoptosis. Mol Cell 14 (2004) 81-93
93. Bartoli M., and Richard I. Calpains in muscle wasting. Int J Biochem Cell Biol 37 (2005) 2115-2133
94. Jackman R.W., and Kandarian S.C. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 287 (2004) C834-C843
95. Menzies F.M., Ravikumar B., and Rubinsztein D.C. Protective roles for induction of autophagy in multiple proteinopathies. Autophagy 2 (2006) 224-225
96. Mizushima N., Levine B., Cuervo A.M., and Klionsky D.J. Autophagy fights disease through cellular self-digestion. Nature 451 (2008) 1069-1075
97. Klionsky D.J., Abeliovich H., Agostinis P., Agrawal D.K., Aliev G., et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4 (2008) 151-175
98. Ciechanover A. Proteolysis: from the lysosome to ubiquitin and the proteasome. Nat Rev Mol Cell Biol 6 (2005) 79-87
99. Mizushima N., and Yoshimori T. How to Interpret LC3 Immunoblotting. Autophagy 3 (2007) 542-545
100. Iwai-Kanai E., Yuan H., Huang C., Sayen M.R., Perry-Garza C.N., Kim L., et al. A method to measure cardiac autophagic flux in vivo. Autophagy 4 (2008) 322-329
101. Shintani T., and Klionsky D.J. Autophagy in health and disease: a double-edged sword. Science 306 (2004) 990-995
102. Zhao J., Brault J.J., Schild A., Cao P., Sandri M., Schiaffino S., et al. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 6 (2007) 472-483
103. Mammucari C., Milan G., Romanello V., Masiero E., Rudolf R., Del Piccolo P., et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 6 (2007) 458-471
104. Pattingre S., Tassa A., Qu X., Garuti R., Liang X.H., Mizushima N., et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122 (2005) 927-939
105. Gustafsson A.B., and Gottlieb R.A. Recycle or die: The role of autophagy in cardioprotection. J Mol Cell Cardiol (2008) Feb 13 (Electronic publication ahead of print)
106. Ravikumar B., Duden R., and Rubinsztein D.C. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum Mol Genet 11 (2002) 1107-1117
107. Webb J.L., Ravikumar B., Atkins J., Skepper J.N., and Rubinsztein D.C. Alpha-Synuclein is degraded by both autophagy and the proteasome. J Biol Chem 278 (2003) 25009-25013
108. Iwata A., Christianson J.C., Bucci M., Ellerby L.M., Nukina N., Forno L.S., et al. Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation. Proc Natl Acad Sci U S A 102 (2005) 13135-13140
109. Komatsu M., Waguri S., Chiba T., Murata S., Iwata J., Tanida I., et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441 (2006) 880-884
110. Hara T., Nakamura K., Matsui M., Yamamoto A., Nakahara Y., Suzuki-Migishima R., et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441 (2006) 885-889
111. Nakai A., Yamaguchi O., Takeda T., Higuchi Y., Hikoso S., Taniike M., et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 13 (2007) 619-624
112. Kruse K.B., Brodsky J.L., and McCracken A.A. Autophagy: an ER protein quality control process. Autophagy 2 (2006) 135-137
113. Mazon M.J., Eraso P., and Portillo F. Efficient degradation of misfolded mutant Pma1 by endoplasmic reticulum-associated degradation requires Atg19 and the Cvt/autophagy pathway. Mol Microbiol 63 (2007) 1069-1077
114. Fujita E., Kouroku Y., Isoai A., Kumagai H., Misutani A., Matsuda C., et al. Two endoplasmic reticulum-associated degradation (ERAD) systems for the novel variant of the mutant dysferlin: ubiquitin/proteasome ERAD(I) and autophagy/lysosome ERAD(II). Hum Mol Genet 16 (2007) 618-629
115. Qin Z.H., Wang Y., Kegel K.B., Kazantsev A., Apostol B.L., Thompson L.M., et al. Autophagy regulates the processing of amino terminal huntingtin fragments. Hum Mol Genet 12 (2003) 3231-3244
116. Shibata M., Lu T., Furuya T., Degterev A., Mizushima N., Yoshimori T., et al. Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1. J Biol Chem 281 (2006) 14474-14485
117. Rideout H.J., Lang-Rollin I., and Stefanis L. Involvement of macroautophagy in the dissolution of neuronal inclusions. Int J Biochem Cell Biol 36 (2004) 2551-2562
118. Harada M., Kumemura H., Omary M.B., Kawaguchi T., Maeyama N., Hanada S., et al. Proteasome inhibition induces inclusion bodies associated with intermediate filaments and fragmentation of the Golgi apparatus. Exp Cell Res 288 (2003) 60-69
119. Ding W.X., Ni H.M., Gao W., Yoshimori T., Stolz D.B., Ron D., et al. Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am J Pathol 171 (2007) 513-524
120. Schroder M., and Kaufman R.J. The mammalian unfolded protein response. Annu Rev Biochem 74 (2005) 739-789
121. Ogata M., Hino S., Saito A., Morikawa K., Kondo S., Kanemoto S., et al. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol 26 (2006) 9220-9231
122. Bjorkoy G., Lamark T., Brech A., Outzen H., Perander M., Overvatn A., et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 171 (2005) 603-614
123. Komatsu M., Waguri S., Koike M., Sou Y.S., Ueno T., Hara T., et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131 (2007) 1149-1163
124. Tanaka Y., Guhde G., Suter A., Eskelinen E.L., Hartmann D., Lullmann-Rauch R., et al. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature 406 (2000) 902-906
125. Hein S., Arnon E., Kostin S., Schonburg M., Elsasser A., Polyakova V., et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 107 (2003) 984-991
126. Yan L., Vatner D.E., Kim S.J., Ge H., Masurekar M., Massover W.H., et al. Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci U S A 102 (2005) 13807-13812
127. Miyata S., Takemura G., Kawase Y., Li Y., Okada H., Maruyama R., et al. Autophagic cardiomyocyte death in cardiomyopathic hamsters and its prevention by granulocyte colony-stimulating factor. Am J Pathol 168 (2006) 386-397
128. Matsui Y., Takagi H., Qu X., Abdellatif M., Sakoda H., Asano T., et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 100 (2007) 914-922
129. Zhu H., Tannous P., Johnstone J.L., Kong Y., Shelton J.M., Richardson J.A., et al. Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest 117 (2007) 1782-1793
130. Hamacher-Brady A., Brady N.R., and Gottlieb R.A. Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem 281 (2006) 29776-29787
131. Bampton E.T., Goemans C.G., Niranjan D., Mizushima N., and Tolkovsky A.M. The dynamics of autophagy visualized in live cells: from autophagosome formation to fusion with endo/lysosomes. Autophagy 1 (2005) 23-36
132. Rothermel B.A., and Hill J.A. Myocyte autophagy in heart disease: friend or foe?. Autophagy 3 (2007) 632-634
133. Matsui Y., Kyoi S., Takagi H., Hsu C.P., Hariharan N., Ago T., et al. Molecular mechanisms and physiological significance of autophagy during myocardial ischemia and reperfusion. Autophagy 4 (2008) 409-415
134. Puthalakath H., O'Reilly L.A., Gunn P., Lee L., Kelly P.N., Huntington N.D., et al. ER stress triggers apoptosis by activating BH3-only protein Bim. Cell 129 (2007) 1337-1349
135. Lin J.H., Li H., Yasumura D., Cohen H.R., Zhang C., Panning B., et al. IRE1 signaling affects cell fate during the unfolded protein response. Science 318 (2007) 944-949
136. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B.A., et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403 (2000) 98-103
137. Saleh M., Mathison J.C., Wolinski M.K., Bensinger S.J., Fitzgerald P., Droin N., et al. Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice. Nature 440 (2006) 1064-1068
138. Harding H.P., Novoa I., Zhang Y., Zeng H., Wek R., Schapira M., et al. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell 6 (2000) 1099-1108
139. Qi X., Vallentin A., Churchill E., and Mochly-Rosen D. deltaPKC participates in the endoplasmic reticulum stress-induced response in cultured cardiac myocytes and ischemic heart. J Mol Cell Cardiol 43 (2007) 420-428
140. Okada K., Minamino T., Tsukamoto Y., Liao Y., Tsukamoto O., Takashima S., et al. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation 110 (2004) 705-712
141. Glembotski C.C. Endoplasmic reticulum stress in the heart. Circ Res 101 (2007) 975-984
142. Kranias E.G., and Bers D.M. Calcium and cardiomyopathies. Subcell Biochem 45 (2007) 523-537
143. Schubert U., Anton L.C., Gibbs J., Norbury C.C., Yewdell J.W., and Bennink J.R. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404 (2000) 770-774
144. Terai K., Hiramoto Y., Masaki M., Sugiyama S., Kuroda T., Hori M., et al. AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress. Mol Cell Biol 25 (2005) 9554-9575
145. Martindale J.J., Fernandez R., Thuerauf D., Whittaker R., Gude N., Sussman M.A., et al. Endoplasmic reticulum stress gene induction and protection from ischemia/reperfusion injury in the hearts of transgenic mice with a tamoxifen-regulated form of ATF6. Circ Res 98 (2006) 1186-1193
146. Menendez-Benito V., Heessen S., and Dantuma N.P. Monitoring of ubiquitin-dependent proteolysis with green fluorescent protein substrates. Methods Enzymol 399 (2005) 490-511
147. Yang J., Moravec C.S., Sussman M.A., DiPaola N.R., Fu D., Hawthorn L., et al. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation 102 (2000) 3046-3052
148. Tsukamoto O., Minamino T., Okada K., Shintani Y., Takashima S., Kato H., et al. Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice. Biochem Biophys Res Commun 340 (2006) 1125-1133
149. Depre C., Wang Q., Yan L., Hedhli N., Peter P., Chen L., et al. Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy. Circulation 114 (2006) 1821-1828
150. Bulteau A.L., Lundberg K.C., Humphries K.M., Sadek H.A., Szweda P.A., Friguet B., et al. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem 276 (2001) 30057-30063
151. Gurusamy N., Goswami S., Malik G., and Das D.K. Oxidative injury induces selective rather than global inhibition of proteasomal activity. J Mol Cell Cardiol 44 (2008) 419-428
152. Herrmann J., Saguner A.M., Versari D., Peterson T.E., Chade A., Olson M., et al. Chronic proteasome inhibition contributes to coronary atherosclerosis. Circ Res 101 (2007) 865-874
153. Bregegere F., Milner Y., and Friguet B. The ubiquitin-proteasome system at the crossroads of stress-response and ageing pathways: a handle for skin care?. Ageing Res Rev 5 (2006) 60-90
154. Bulteau A.L., Szweda L.I., and Friguet B. Age-dependent declines in proteasome activity in the heart. Arch Biochem Biophys 397 (2002) 298-304
155. Powell S.R., Wang P., Divald A., Teichberg S., Haridas V., McCloskey T.W., et al. Aggregates of oxidized proteins (lipofuscin) induce apoptosis through proteasome inhibition and dysregulation of proapoptotic proteins. Free Radic Biol Med 38 (2005) 1093-1101
156. Spoerri P.E., Glees P., and El Ghazzawi E. Accumulation of lipofuscin in the myocardium of senile guinea pigs: dissolution and removal of lipofuscin following dimethylaminoethyl p-chlorophenoxyacetate administration. An electron microscopic study. Mech Ageing Dev 3 (1974) 311-321
157. Kostin S., Pool L., Elsasser A., Hein S., Drexler H.C., Arnon E., et al. Myocytes die by multiple mechanisms in failing human hearts. Circ Res 92 (2003) 715-724
158. Sanbe A., Osinska H., Villa C., Gulick J., Klevitsky R., Glabe C.G., et al. Reversal of amyloid-induced heart disease in desmin-related cardiomyopathy. Proc Natl Acad Sci U S A 102 (2005) 13592-13597
159. Maloyan A., Gulick J., Glabe C.G., Kayed R., and Robbins J. Exercise reverses preamyloid oligomer and prolongs survival in alphaB-crystallin-based desmin-related cardiomyopathy. Proc Natl Acad Sci U S A 104 (2007) 5995-6000
160. Sarikas A., Carrier L., Schenke C., Doll D., Flavigny J., Lindenberg K.S., et al. Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants. Cardiovasc Res 66 (2005) 33-44
161. Liu J., Tang M., Mestril R., and Wang X. Aberrant protein aggregation is essential for a mutant desmin to impair the proteolytic function of the ubiquitin-proteasome system in cardiomyocytes. J Mol Cell Cardiol 40 (2006) 451-454
162. Sanbe A., Yamauchi J., Miyamoto Y., Fujiwara Y., Murabe M., and Tanoue A. Interruption of CryAB-amyloid oligomer formation by HSP22. J Biol Chem 282 (2007) 555-563
163. Bennett E.J., Bence N.F., Jayakumar R., and Kopito R.R. Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Mol Cell 17 (2005) 351-365
164. Kristiansen M., Deriziotis P., Dimcheff D.E., Jackson G.S., Ovaa H., Naumann H., et al. Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol Cell 26 (2007) 175-188
165. Goldberg A.L. On prions, proteasomes, and mad cows. N Engl J Med 357 (2007) 1150-1152
166. Maloyan A., Sanbe A., Osinska H., Westfall M., Robinson D., Imahashi K., et al. Mitochondrial dysfunction and apoptosis underlie the pathogenic process in alpha-B-crystallin desmin-related cardiomyopathy. Circulation 112 (2005) 3451-3461
167. Jin J.K., Whittaker R., Glassy M.S., Barlow S.B., Gottlieb R.A., and Glembotski C.C. Localization of phosphorylated alphaB-crystallin to heart mitochondria during ischemia-reperfusion. Am J Physiol Heart Circ Physiol 294 (2008) H337-H344
168. Kadono T., Zhang X.Q., Srinivasan S., Ishida H., Barry W.H., and Benjamin I.J. CRYAB and HSPB2 deficiency increases myocyte mitochondrial permeability transition and mitochondrial calcium uptake. J Mol Cell Cardiol 40 (2006) 783-789
169. Zhang C., Xu Z., He X.R., Michael L.H., and Patterson C. CHIP, a cochaperone/ubiquitin ligase that regulates protein quality control, is required for maximal cardioprotection after myocardial infarction in mice. Am J Physiol Heart Circ Physiol 288 (2005) H2836-H2842
170. Pye J., Ardeshirpour F., McCain A., Bellinger D.A., Merricks E., Adams J., et al. Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury. Am J Physiol Heart Circ Physiol 284 (2003) H919-H926
171. Luss H., Schmitz W., and Neumann J. A proteasome inhibitor confers cardioprotection. Cardiovasc Res 54 (2002) 140-151
172. Voortman J., and Giaccone G. Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report. BMC Cancer 6 (2006) 129
173. Ciolli S., Leoni F., Gigli F., Rigacci L., and Bosi A. Low dose Velcade, thalidomide and dexamethasone (LD-VTD): an effective regimen for relapsed and refractory multiple myeloma patients. Leuk Lymphoma 47 (2006) 171-173
174. Enrico O., Gabriele B., Nadia C., Sara G., Daniele V., Giulia C., et al. Unexpected cardiotoxicity in haematological bortezomib treated patients. Br J Haematol 138 (2007) 396-397